China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- Expats explore roots of Chinese civilization in Hangzhou
- Scientific community, netizens pay tribute to late Nobel laureate Yang Chen-Ning
- Ancient Confucian ideas inspire today
- US professor eyes retirement in Wuyi Mountains
- Guyuan promotion conference enhances Ningxia and Jiangsu ties
- ECNU's intl student program benefits mother and daughter from Vietnam
